Merck KGaA (OTCMKTS:MKKGY) Hits New 12-Month Low – Should You Sell?

Merck KGaA (OTCMKTS:MKKGY)’s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $27.19 and last traded at $27.23, with a volume of 47833 shares changing hands. The stock had previously closed at $28.26.

Merck KGaA Stock Down 3.6 %

The firm has a market cap of $17.60 billion, a P/E ratio of 16.81, a PEG ratio of 2.05 and a beta of 0.98. The firm’s 50-day moving average price is $29.22 and its 200 day moving average price is $31.10. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91.

Merck KGaA (OTCMKTS:MKKGY) last released its earnings results on Thursday, March 6th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. The company had revenue of $5.78 billion for the quarter, compared to the consensus estimate of $5.40 billion. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. On average, equities research analysts expect that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.